Read our scientific publications and keep up with us in the news.


Azitra Presents Data Showing Tolerability of its Lead Product Candidate ATR-04

Azitra, Inc. Appoints Mark Sampson, Ph.D. as Chief Scientific Officer

Azitra, Inc. Expands Research and Development Team to Support Clinical Development Program

Azitra Receives Ongoing Support for its Netherton Development Program from the National Science Foundation (NSF)

Azitra Demonstrates Feasibility of Engineering the Skin Microbiome to Treat Serious Skin Conditions

Chardan’s 1st Annual Microbiome Summit

Azitra featured as “Company to Watch” by Life Science Leader

Azitra’s Clinical Study of ATR-04 for Cosmetic Use Completes Enrollment

Pharmabiotics Conference 

North American Microbiome Congress

Microbiome Drug Development Summit Europe

Azitra to Present at the Biotech Showcase™ Annual Conference on January 7, 2019

Azitra to Present at the Biotech Showcase™ Annual Conference on January 7, 2019

European Skin Microbiome Congress

Azitra and Jackson Labs Receive Department of Defense Grant for Next-Generation Anti-Infectives

Azitra Awarded NIH SBIR Grant to Develop Microbiome-based Therapeutic for Netherton Syndrome

Cosmetics & Toiletries

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

Azitra to Present at the Biotech Showcase™ Annual Conference on January 8, 2018

Azitra Founder Travis Whitfill, MPH named Forbes “30 under 30 in Healthcare”

Richard Andrews Appointed CEO

Julia Oh, Ph.D., Multi-Award winner

Azitra Raises $3.75 Million

Research from Azitra affiliates

Kong, H.H., Oh, J., et al., Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res, 2012. 22(5): p. 850-9.

Oh, J., et al., Biogeography and individuality shape function in the human skin metagenome. Nature, 2014. 514(7520): p. 59-64

Oh, J., et al., The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res, 2013. 23(12): p. 2103-14.

Oh, J., et al., Temporal Stability of the Human Skin Microbiome. 5;165(4):854-66.

Oh, J., et al., Shifts in human skin and nares microbiota of healthy children and adults. Genome Med, 2012. 10;4(10):77.


S. epidermidis-specific

Stacy A., Belkaid Y. Microbial guardians of skn Health. Science. 2019. 18;363(6424):227-228

Linehan, J.L., et al., Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell, 2018.

Nakatsuji, T., et al., Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med, 2017. 9(378).

Scharschmidt, T.C., et al., Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin. Cell Host Microbe, 2017. 21(4): p. 467-477.e5.

Naik, S., et al., Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature, 2015. 520(7545): p. 104-8.

Scharschmidt, Tiffany C., et al., A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes. Immunity, 2015. 43(5): p. 1011-1021

Nodake, Y., et al., Pilot study on novel skin care method by augmentation with Staphylococcus epidermidis, an autologous skin microbe – A blinded randomized clinical trial. J Dermatol Sci, 2015. 79(2): p. 119-26.

Skin microbiome reviews

Belkaid, Y. and O.J. Harrison, Homeostatic Immunity and the Microbiota. Immunity, 2017. 46(4): p. 562-576.

Byrd, A.L., et al., Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Science translational medicine, 2017. 9(397): p. eaal4651.

Belkaid, Y. and S. Tamoutounour, The influence of skin microorganisms on cutaneous immunity. Nat Rev Immunol, 2016. 16(6): p. 353-66.

Grice, E.A. and J.A. Segre, The skin microbiome. Nat Rev Microbiol, 2011. 9(4): p. 244-53

Naik, S., et al., Compartmentalized control of skin immunity by resident commensals. Science, 2012. 337(6098): p. 1115-9.